First AD

Second AD

Optimizing First-Line Therapy for Limited-Stage Small Cell Lung Cancer

Briefly explore the current landscape of 

 for limited-stage small cell lung cancer:

What clinical factors influence or impact the initial diagnostic workup and management of patients with LS-SCLC?

To what degree is a multidisciplinary team approach adopted when developing a treatment plan for patients with SCLC?

With respect to limited-stage disease, which patients are most likely to benefit from surgery and does lobectomy remain the preferred procedure for stageI-IIA (T1-2,N0,M0) disease?

To what degree does pathologic mediastinal lymph node stage influence your treatment path?

Under what circumstances would surgery versus RT be a preferred approach for a patient with stage I-IIA SCLC?

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


Lung Cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Video Series

ASCO 2024: Immunotherapy for the Treatment of Small Cell Lung Cancer

Peer Exchange

Medical experts in small cell lung cancer convene to examine first-line treatments, ongoing clinical trials, and emerging therapies shaping the evolving treatment landscape.